Annika Hanberg

Annika Hanberg is a Professor of Toxicology at the Institute of Environmental Medicine at Karolinska Institutet, Sweden. She serves as Programme Director for the Global Master's Programme in Toxicology since 2006 and has been a leading figure in health risk assessment for national agencies, EU bodies, and the WHO since the 1980s. Her work focuses on methodological advancements in risk assessment, including systematic reviews, mixture toxicity, endocrine disruptors, and dose-response evaluation. She co-leads the Health Risk Assessment Methodology Group under Anna Beronius and is a key member of the Horizon Europe-funded PARC (Partnership for Risk Assessment of Chemicals) initiative.

Research & Expertise: Her expertise spans experimental toxicology, risk assessment method development, and regulatory support. She has pioneered frameworks for evaluating non-monotonic dose responses and chemical mixtures. She organizes international training courses in risk assessment methodologies and has contributed to EFSA guidelines on uncertainty analysis and weight-of-evidence approaches.

Grants & Collaborations: Active in major projects such as PARC (2022–2029) and SciRAP (Swedish Research Council), focusing on improving risk assessment tools and transparency. She has secured funding for studies on gender-specific chemical risks and the implementation of alternative toxicology methods.

Professional Roles: Dr. Hanberg is an European Registered Toxicologist, Orcid-linked researcher, and LinkedIn-profiling academic. She advises on regulatory science and participates in global initiatives to strengthen chemical risk analysis capacities, particularly in Nordic regions.